Skip to content
Saturday, November 7, 2026
Bright World Network

Giving Pluripotent Cells During Pregnancy to Babies with Spina Bifida Boosts Life Outcomes, Study Reveals

A pioneering medical trial has discovered that administering stem cells to fetuses diagnosed with spina bifida while undergoing fetal surgery can be a "important advancement" in treating birth defects.

Trial Details and Safety

The US-based trial focused on six unborn babies with the 'open' form of spina bifida. Doctors administered mother's placental stem cells directly onto the infant's spine as part of the surgical correction.

Importantly, the stem cell application was found to be safe. Researchers confirmed that the cells did not cause tumors, disrupt the healing process, or prevent the reversal of co-occurring hindbrain herniation.

Positive Developments

Imaging conducted after delivery indicated a successful correction of hindbrain herniation in each of the babies. This favorable anatomical change is closely linked to better mobility and function.

"In the event it allows additional babies able to walk who previously could not, it could establish itself as the new treatment paradigm," commented the principal investigator. "The outcomes appear extremely promising and open the door to lots of potential innovative interventions."

Future Implications and Hope

Independent medical specialists indicated that subsequent studies of these apparent benefits could announce a "new era" in prenatal intervention. The potential to improve neurological damage seen in utero is viewed as a transformative goal.

Particularly welcome would be improvements in continence and digestive health, which are common challenges for those diagnosed with this defect.

The Path Forward

Despite this being a first-in-human effort focused on a handful of cases, its safety demonstration and positive signals create a solid basis for broader investigative efforts. The combination of regenerative medicine with proven prenatal surgical methods holds considerable promise for improving the prognosis for babies yet to be born with this neural tube defect.

About the author

Stacey Kirby

Elena Voss is a tech journalist and global innovation strategist with a passion for cross-cultural collaboration.

Bright World Network

Type to search articles.